Urol. praxi. 2022;23(1):6-11 | DOI: 10.36290/uro.2021.034

Lower urinary tract dysfunction in a diabetic patient

MUDr. Miroslava Ryšánková
Urologie Náchod, s. r. o., Náchod

Nervous and neuromuscular diseases affect the proper function of the lower urinary tract. Diabetes mellitus is one of the diseases that has a significant effect on the dysfunction of this function, especially the development of peripheral neuropathy. In the first phase, it leads to the development of overactive bladder syndrome, when left untreated, there is a loss of sensitivity and an increase in urine residue, up to urinary retention. We are talking about diabetic cystopathy. The detection of the stage of urinary tract involvement is preceded by a thorough examination of the patient. Follow-up treatment is usually lengthy. Patients with this diagnosis should always be monitored, even with regard to the unpredictability of the primary disease and the tendency for symptoms to change over time.

Keywords: diabetes mellitus, neurogenic bladder, urinary tract dysfunction.

Received: October 24, 2021; Revised: October 24, 2021; Accepted: November 7, 2021; Prepublished online: November 7, 2021; Published: March 16, 2022  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Ryšánková M. Lower urinary tract dysfunction in a diabetic patient. Urol. praxi. 2022;23(1):6-11. doi: 10.36290/uro.2021.034.
Download citation

References

  1. Češka R, et al. Interna. 3. vydání. Praha: Triton, 2020; 970 s.
  2. Pelikánová T, Bartoš V. Praktická diabetologie. 6 ed. Praha: Maxdorf, 2018;815 s.
  3. Hanuš T. Dysfunkce dolních močových cest. In: Dvořáček J. Urologie III. ISV Praha, 1998;1307-1333.
  4. Abrams P, Cardozo L, Fall M, et al. The standardisation of terminology in lower urinary tract function: report from the standardisation sub­‑committee of the International Continence Society. Urology. 2003;61(1):37-49. Go to original source... Go to PubMed...
  5. Madersbacher H. The neuropathic uretra: urethrogram and pathophysiologic aspects. Eur Urol. 1977;3:321-332. Go to original source... Go to PubMed...
  6. Yamaguchi C, Sakakibara R, Uchiyama T, et al. Overactive bladder in diabetes: a peripheral or central mechanism? Neurourol Urodyn. 2007;26:807. Go to original source... Go to PubMed...
  7. Pinna CH, Zanardo R, Puglisi L. Prostaglandin release impairment in the bladder epithelium of the streptozotocin induced diabetic rats. Eur Pharmacol. 2000;388:267. Go to original source... Go to PubMed...
  8. Geerlings SE, Meiland R, van Lith EC, et al. Adherence of type 1-fimbriated Escherichia coli to uroepithelial cells, more in diabetic women than in control subjects. Diabetes Care. 2002;25:140. Go to original source... Go to PubMed...
  9. Birnbaum, H, Leong S, Kabra, A. Lifetime medical costs for women: cardiovascular disease, diabetes and stress urinary incontinence. Women Health Issue. 2003;13:204-213. Go to original source... Go to PubMed...
  10. Manning J, Korda A, Benness C, et al. The association of obstructive defecation, lower urinary tract dysfunction and the benign joint hypermobility syndrome, a case control study. Int. Urogynecology J Pelvic Floor Dysfunction. 2003;14:128-132. Go to original source... Go to PubMed...
  11. Yuan Z, Tang Z, He Ch, et al. Diabetic cystopathy: a review. J Diabetes. 2015;7(4):442-447. Go to original source... Go to PubMed...
  12. Daneshgari F, Liu G, Imrey PB. Time dependent changes in diabetic cystopathy in rats include compensated and decompensated bladder function. J Urol. 2006;176:380-386. Go to original source... Go to PubMed...
  13. Mumtaz FH, Sullivan ME, Thompson CS, et al. Alterations in the nitric oxide synthase binding sites and non­‑adrenergic, non­‑cholinergic mediated smooth muscle relaxation in the diabetic rabbit bladder outlet: possible relevance to the pathogenesis of diabetic cystopathy. J Urol. 1999;162:558. Go to original source... Go to PubMed...
  14. Krhut J, et al. Neurourologie. Praha: Galén 2005;87:95 s.
  15. Maman K, Aballea S, Nazir J, et al. Comparative effi cacy and safety of medical treatments for the management of overactive bladder: a systematic literature review and mixed treatment comparison. Eur Urol. 2014;65:755-765. Go to original source... Go to PubMed...
  16. Lacigová S, Rušavý Z, Jirkovská A, et al. Doporučený postup diagnostiky a léčby diabetické neuropatie (2016), doporučení České diabetologické společnosti ČLS JEP. Datum revize 23. 2. 2016. Dmev. 2016;19(2):57-63.
  17. Minirin, souhrn údajů o přípravku, sp.zn.sukls1-85737/2018.




Urology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.